Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Pieter F Stam"'
Role of osteopontin as a predictive biomarker for anti-EGFR therapy in triple-negative breast cancer
Publikováno v:
Expert opinion on therapeutic targets. 22(8)
Effective targeted therapies for patients with triple-negative breast cancer (TNBC) present an unmet clinical need. There is evidence that TNBCs often have increased expression of the epidermal growth factor receptor (EGFR) and of osteopontin (OPN).